Land: USA
Språk: engelsk
Kilde: NLM (National Library of Medicine)
LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987)
ridge properties llc
TOPICAL
OTC DRUG
OTC monograph not final
SUPERIOR PAIN AND ITCH RELIEF- LIDOCAINE HCL LIQUID RIDGE PROPERTIES LLC _Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they_ _comply with applicable regulations and policies. FDA has not evaluated whether this product complies._ ---------- SUPERIOR PAIN AND ITCH RELIEF lidocaine hcl liquid PRODUCT INFORMATION PRODUCT T YPE HUMAN OTC DRUG ITE M CODE (SOURCE ) NDC:6 9 8 0 4-0 71 ROUTE OF ADMINISTRATION TOPICAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH LIDO CAINE HYDRO CHLO RIDE (UNII: V130 0 7Z41A) (LIDOCAINE - UNII:9 8 PI20 0 9 8 7) LIDOCAINE HYDROCHLORIDE ANHYDROUS 40 mg in 10 0 0 mg INACTIVE INGREDIENTS INGREDIENT NAME STRE NG TH BENZYL ALCO HO L (UNII: LKG8 49 4WBH) 10 mg in 10 0 0 mg PIPER METHYSTICUM RO O T (UNII: BOW48 C8 1XP) 11 mg in 10 0 0 mg ridge properties llc PRO PYLENE GLYCO L (UNII: 6 DC9 Q16 7V3) 6 8 9 mg in 10 0 0 mg CARBO MER INTERPO LYMER TYPE A ( ALLYL SUCRO SE CRO SSLINKED) (UNII: 59 TL3WG5CO) 1 mg in 10 0 0 mg WATER (UNII: 0 59 QF0 KO0 R) 6 9 mg in 10 0 0 mg CO PAIBA O IL (UNII: 6 4VX45Y6 8 N) 18 0 mg in 10 0 0 mg PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:6 9 8 0 4-0 71- 0 7 28 50 0 mg in 1 BOTTLE, SPRAY; Type 0 : No t a Co mbinatio n Pro duc t 11/27/20 17 2 NDC:6 9 8 0 4-0 71- 0 1 56 70 0 mg in 1 BOTTLE, SPRAY; Type 0 : No t a Co mbinatio n Pro duc t 11/27/20 17 3 NDC:6 9 8 0 4-0 71- 0 4 11340 0 mg in 1 BOTTLE, SPRAY; Type 0 : No t a Co mbinatio n Pro duc t 11/27/20 17 MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITATION MARKE TING START DATE MARKE TING END DATE OTC mo no graph no t final pa rt348 11/27/20 17 LABELER - ridge properties llc (029478762) ESTABLISHMENT NAME AD D RE S S ID/FEI BUSINE SS OPE RATIONS ridge pro perties llc 0 29 478 76 2 ma nufa c ture (6 9 8 0 4-0 71) Revised: 6/2020 read_full_document